MatsukiyoCocokara & Co.

3088

JP3869010003

Drug Retailers

Market Closed - Japan Exchange Other stock markets 11:30:00 09/05/2024 am IST			5-day change	1st Jan Change
2,262 ^JPY	+1.09%		+0.20%	-9.39%

28/02	Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- 2nd Update	DJ
28/02	Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- Update	DJ

Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on August 12, 2022.

August 15, 2022 at 06:30 am IST

From August 12, 2022 to August 15, 2022, the company has repurchased 600,000 shares, representing 0.42% for ¥3,084 million. With this, the company has completed the repurchase of 600,000 shares, representing 0.42% for ¥3,084 million under the buyback announced on August 12, 2022.

Latest news about MatsukiyoCocokara & Co.

Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- 2nd Update	28/02	DJ
Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- Update	28/02	DJ
Aeon Co. Weighs Merger of Drugstore Unit Welcia With Rival Tsuruha -- 3rd Update	26/02	DJ
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on November 14, 2023.	15/11	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on November 14, 2023, has closed with 715,200 shares, representing 0.17% for ¥1,941.77 million.	15/11	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 800,000 shares, representing 0.19% for ¥2,172 million.	14/11	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	14/11	CI
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on August 10, 2023.	14/23/14	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on August 10, 2023, has closed with 200,000 shares, representing 0.14% for ¥1,742 million.	14/23/14	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 220,000 shares, representing 0.16% for ¥1,936 million.	10/23/10	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	10/23/10	CI
MatsukiyoCocokara & Co. Reports Earnings Results for the Full Year Ended March 31, 2023	12/23/12	CI
Morgan Stanley Adjusts MatsukiyoCocokara's Price Target to 8,300 Yen From 6,600 Yen, Keeps at Overweight	11/23/11	MT
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on February 14, 2023.	15/23/15	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on February 14, 2023, has closed with 1,150,000 shares, representing 0.82% for ¥7,555.50 million.	15/23/15	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 1,250,000 shares, representing 0.89% for ¥8,500 million.	14/23/14	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	14/23/14	CI
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on November 14, 2022.	15/22/15	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on November 14, 2022, has closed with 204,000 shares, representing 0.14% for ¥1,071 million.	15/22/15	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 230,000 shares, representing 0.16% for ¥1,500 million.	14/22/14	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	14/22/14	CI
MatsukiyoCocokara & Co.(TSE:3088) added to S&P Japan Mid Cap 100	20/22/20	CI
Nikkei hits over 7-month high on Wall Street optimism, robust earnings	15/22/15	RE
Japanese shares rise on Wall Street optimism, strong earnings	15/22/15	RE
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on August 12, 2022.	15/22/15	CI

Chart MatsukiyoCocokara & Co.

Duration

Period

More charts

Company Profile

MatsukiyoCocokara & Co, formerly Matsumotokiyoshi Holdings Co Ltd, is engaged in retail business, wholesale business and management support business. Retail business is engaged in operating chain stores of drugstores and insurance pharmacies, opening and operating insurance dispensing pharmacies, dispatching pharmacists and others. Wholesale business purchases and sells products handled by group companies and business partners that engage in retail business, develops franchise businesses, and supplies products to franchisees. The Management Support segment is involved in the management of group companies and contracting of indirect business, planning and development of private brand products, asset management and operation, the construction and maintenance of stores, as well as the operation of non-life and life insurance agency business.

Sector

Drug Retailers

Calendar

10/05/2024 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for MatsukiyoCocokara & Co.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2,262 JPY

Average target price

3,031 JPY

Spread / Average Target

+33.96%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
MATSUKIYOCOCOKARA & CO.	-9.39%	6B
WALGREENS BOOTS ALLIANCE, INC.	-33.93%	14.86B
JD HEALTH INTERNATIONAL INC.	-23.66%	11.73B
YIFENG PHARMACY CHAIN CO., LTD.	+16.46%	6.3B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-25.24%	6.29B
NAHDI MEDICAL COMPANY	-2.34%	4.63B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+60.00%	4.57B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-8.19%	3.5B
WELCIA HOLDINGS CO., LTD.	-6.41%	3.04B
REDCARE PHARMACY NV	-4.64%	2.78B

Other Drug Retailers

MatsukiyoCocokara & Co.

Equities

3088

JP3869010003

Drug Retailers

Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on August 12, 2022.

EPS Revisions